http://web.archive.org/web/20150425001430id_/http://www.dailymail.co.uk/health/article-2524442/14p-day-tablet-ease-pain-millions-arthritis-sufferers-dangerous-effects.html

scientists believe they can help millions of people suffering from arthritis with a new 14p - a - day tablet			0
spironolactone , usually used for high blood pressure and heart failure , could help people with osteoarthritis , it is claimed			1
the research at @entity11 has shown it could be a breakthrough for the six million people suffering from the debilitating condition across the country			2
new drug : spironolactone , usually used for high blood pressure , could help people with osteoarthritis initial tests showed it has painkilling potential and now the scientists are setting up more trials to see its full potential , the @entity20 reports			1
professor @entity26 , medical director of @entity27 , has put Â£ 135,000 towards the cost of the research			0
he said : ' spironolactone has been around for decades so we know it is safe			2
' osteoarthritis is most common among older people and causes swelling and stiffness in joints			0
there is no cure for the extremely painful condition and long - term treatment can include having artificial joints			0
debilitating : osteoarthritis is most common among older people and causes swelling and stiffness in joints researchers found @entity30 , which lowers blood pressure , also works to lessen pain in arthritis sufferers			1
the study , lead by professor @entity52 , head of ageing and health at @entity11 , gave 25mg of the drug every day for five months and found it helped sufferers			1
researchers are now bringing in 86 patients , all aged 70 or over , to carry out further tests			0
these patients will either be given the drug or a placebo over a 12 week period and the results will help determine if their theory is correct .			2

existing drug spironolactone is being tested on patients
the drug is usually used for high blood pressure and heart failure
more trials are being set up by @entity11 to test its potential

@entity30:Spironolactone
@entity20:Express
@entity26:Alan Silman
@entity27:Arthritis Research UK
@entity11:Dundee University
@entity52:Marion McMurdo